상품명칭 |
디하이드로우아바인 |
별명 |
디하이드로우아바인; 4-18-00-03552 (Beilstein 핸드북 참조); BRN 0071786; 디하이드로-g-스트로파틴; 디하이드로루아빈; (20xi) - 3beta ((6-Deoxy 알파 L mannopyranosyl) oxy) - 1beta, 5beta, 11alpha, 14,19-pentahydroxycardanolide; 5-베타-20-xi-카르다놀라이드, 3-베타-((6-데옥시-알파-L-만노피라노실)옥시)-1-베타,5,11-알파,14,19-펜타하이드록시-; Ouabain, dihydro- (7CI); 3-[(6-데옥시헥소피라노실)옥시]-1,5,11,14,19-펜타하이드록시카르다놀라이드; (1beta, 3beta, 5beta, 8xi, 9xi, 17xi, 20xi) -3 [(6- 데 옥시 - 베타 -L- 글리세로 - 헥소 피라 노 실) 옥시] -1,5,11,14,19- 펜타 하이드 록시 카르 다놀 라이드; 4-[(1R,3S,5S,9S,10R,11R,13R,14S,17R)-1,5,11,14-테트라하이드록시-10-(하이드록시메틸)-13-메틸-3-[(2R,3R,4R,5R,6S)-3,4,5-트리하이드록시-6-메틸-테트라히드로피란-2-일]옥시-2,3,4,6,7,8,9,11,12,15,16,17-도데카하이드로-1H-사이클로펜타[a]페난트렌-17-일]테트라하이드로푸란-2-온 |
영문 이름 |
dihydroouabain;Dihydroouabain; 4-18-00-03552 (Beilstein Handbook Reference); BRN 0071786; Dihydro-g-strophathin; Dihydroouabin; (20xi)-3beta-((6-Deoxy-alpha-L-mannopyranosyl)oxy)-1beta,5beta,11alpha,14,19-pentahydroxycardanolide; 5-beta-20-xi-Cardanolide, 3-beta-((6-deoxy-alpha-L-mannopyranosyl)oxy)-1-beta,5,11-alpha,14,19-pentahydroxy-; Ouabain, dihydro- (7CI); 3-[(6-deoxyhexopyranosyl)oxy]-1,5,11,14,19-pentahydroxycardanolide; (1beta,3beta,5beta,8xi,9xi,17xi,20xi)-3-[(6-deoxy-beta-L-glycero-hexopyranosyl)oxy]-1,5,11,14,19-pentahydroxycardanolide; 4-[(1R,3S,5S,9S,10R,11R,13R,14S,17R)-1,5,11,14-tetrahydroxy-10-(hydroxymethyl)-13-methyl-3-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]tetrahydrofuran-2-one |
분자식 |
C29H46O12 |
분자량 |
586.6683 |
InChI |
InChI=1/C29H46O12/c1-13-22(34)23(35)24(36)25(40-13)41-15-8-19(32)28(12-30)21-17(3-5-27(28,37)9-15)29(38)6-4-16(14-7-20(33)39-11-14)26(29,2)10-18(21)31/h13-19,21-25,30-32,34-38H,3-12H2,1-2H3/t13-,14?,15-,16+,17?,18+,19+,21+,22-,23+,24+,25-,26+,27-,28+,29-/m0/s1 |
cas번호 |
1183-35-3 |
EC번호 |
214-663-0 |
분자 구조 |
|
밀도 |
1.496g/cm3 |
비등점 |
827.723°C at 760 mmHg |
굴절 지수 |
1.641 |
인화점 |
268.458°C |
증기압 |
0mmHg at 25°C |
위험성 표시 |
|
리스크 규칙 |
|
보안 규칙 |
|
|